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IQGAP1 contains a number of protein recognition motifs through which it binds to targets. Several in vitro studies have documented that IQGAP1 interacts directly with calmodulin, actin, E-cadherin, β-catenin, and the small GTPases Cdc42 and Rac. Nevertheless, direct demonstration of in vivo function of mammalian IQGAP1 is limited. Using a novel assay to evaluate in vivo function of IQGAP1, we document here that microinjection of IQGAP1 into early Xenopus embryos generates superficial ectoderm lesions at late blastula stages. 
INTRODUCTION
The Ras superfamily of GTPases, which has over 80 members, can be divided into several subfamilies. One of these, the Rho family, is comprised of fourteen GTPases, the most extensively characterized of which are Rho, Rac and Cdc42 (1) (2) (3) . The GTPases cycle between an inactive GDP-bound and an active GTP-bound form. In addition to controlling organization of the cytoskeleton, Cdc42 participates in cell movement, cell cycle progression, gene transcription and cell-cell attachment (1, 2, 4) . These functions are elicited via target proteins which are regulated by direct interaction with GTP-Cdc42. Effectors include p21-activated kinases (5), the Wiskott-Aldrich syndrome protein (WASP) (6) , the ACK tyrosine kinase (7) , and IQGAP1 (8) (9) (10) (11) . IQGAP1, originally isolated from metastatic human osteosarcoma tissue (12) , contains an IQ domain and a C-terminal region with sequence similarity to the catalytic domain of Ras GTPase activating proteins (GAPs). IQGAP1 contains several protein recognition motifs through which it binds to a number of targets. These motifs include a calponin homology domain (CHD), which binds actin (13); a WW polyproline-binding domain; four IQ motifs, which bind calmodulin (9,13); and a Ras-GAP related domain (GRD), which is necessary for Cdc42 and Rac1 binding (10) . In addition, E-cadherin and β-catenin bind directly to IQGAP1 (14) (15) (16) . IQGAP1 homologues, termed Iqg1/Cyk1p, Rng2p and DGAP1, have been identified in S. cervesiae, S. pombe and D. discoideum, respectively (17) (18) (19) (20) .
Functional analysis reveals that yeast IQGAP1-related protein is an important regulator of cellular morphogenesis and induces actin-ring formation during cytokinesis (17, 18) . The function(s) of mammalian IQGAP1 are less clear. In vitro assays have demonstrated that mammalian IQGAP1 inhibits the intrinsic GTPase activity of Cdc42, keeping it in the active 5 GTP-bound state (13) . Similar inhibition was obtained in vitro with the C-terminal half of IQGAP1 (21) . Moreover, mammalian IQGAP1 cross-links actin filaments in vitro (22, 23) and may have a role in cell-cell adhesion (14, 16) . However, direct demonstration of in vivo function of mammalian IQGAP1 is limited. In the present study we demonstrate that IQGAP1 interferes with Xenopus embryogenesis in vivo, by causing development of ectodermal lesions around the site of RNA microinjection. This effect was not observed with mutant forms of IQGAP1 that do not bind Cdc42 and was abrogated by N17Cdc42, a dominant negative Cdc42 construct, indicating the important role of the interaction between IQGAP1 and Cdc42 in vivo.
EXPERIMENTAL PROCEDURES
IQGAP1 Plasmid Construction -A Myc-tagged wild type human IQGAP1 in pcDNA3 vector (9) was used. IQGAP1 lacking the IQ region (IQGAP1-∆IQ; amino acids 699-905 deleted) or the C-terminal region (IQGAP1-∆C; amino acids 1502-1657 deleted) were described previously (16) . 
RESULTS
The Effect of IQGAP1 on Xenopus Ectoderm -To gain insight into IQGAP1 functions, we synthesized mRNA encoding full length IQGAP1 protein and injected it into Xenopus early embryos, a rapid in vivo model for gene expression. Injected embryos developed normally until midblastula stages, when compared to uninjected controls (Fig. 1) . At mid-late blastula stages, depigmentation of embryonic blastomeres was observed around the injection site, suggesting that pigment granules lost their cortical localization due to rearrangement of cytoskeletal structure (30). By gastrulation, the animal hemisphere of injected embryos developed ectodermal lesions, in which cells appeared to have lost adhesion (Fig. 1) . These lesions were observed in the majority of injected embryos (77%, n=92). By contrast, control uninjected embryos and embryos injected with LacZ RNA developed normally (Fig. 1, n=150 , and data not shown). The observed morphological abnormalities of embryos overexpressing IQGAP1 reflect an in vivo activity of IQGAP1 and provide a novel functional assay.
Binding of Cdc42 to IQGAP1 -In order to identify the target which mediated the IQGAP1 effect on embryonic ectoderm, we generated a series of mutant forms of IQGAP1 ( Fig. 2A) . All of the major identified protein interaction motifs and the C-terminal tail of IQGAP1 were individually deleted. The ability of these mutant constructs to bind endogenous Cdc42 was examined. CHO cells were transiently transfected with IQGAP1 and equal amounts of cell lysate were immunoprecipitated. As previously demonstrated (13), Cdc42 co-immunoprecipitated with wildtype IQGAP1 (Fig. 2B) . Deletion of the CHD or WW domains did not alter binding of Cdc42 to 11 GRD or the C-terminal region of IQGAP1 (Fig. 2B) . Because endogenous IQGAP1 concentrations in CHO cells are low, the amount of recombinant IQGAP1 is several fold higher than the endogenous protein (Fig. 2C , compare vector and IQGAP1-transfected samples).
Effect of Mutant IQGAP1 Constructs on Xenopus Ectoderm -To define which domain of IQGAP1 is critical for its functional activity in embryonic ectoderm, we tested the ability of different mutated forms of IQGAP1 to induce ectodermal lesions. RNA microinjections revealed that deletion of the CHD or WW domains did not alter the activity of IQGAP1 (n=70 and n=62, respectively), whereas deletion of the IQ domain, the GRD or the C-terminus of IQGAP1 completely abrogated its activity in early embryos (Fig. 3A, n=61 , 76 and 49, respectively).
To ensure that the injected mRNA was translated into protein, after microinjection embryos were lysed and proteins were resolved by SDS-PAGE. Immunoblotting revealed that all of the IQGAP1 constructs were expressed (Fig. 3B) . Probing the blots for actin verified that equal amounts of protein lysate were loaded on the gel (Fig. 3B) . These findings confirm that the indicated IQGAP1 mutants, although present, did not have a functional effect. Importantly, the constructs that lost functional activity are the same constructs that no longer bind Cdc42 (Fig.   2B ). This result indicates that the binding of Cdc42 is essential for the functional activity of IQGAP1 in the embryos.
The Effect of IQGAP1 on Animal Pole Cells Requires Cdc42 -Comparison of mutant constructs
suggested that the property of IQGAP1 to produce ectodermal lesions may be due to the modulation of the activities of the Rho family GTPases in early embryos. To address this 12 hypothesis, we compared the amount of active Cdc42 that binds GST-WASP-GBD (24) in embryos injected with the wild-type or mutant IQGAP1. Since GST-WASP-GBD binds only GTP-bound Cdc42, the amount of bound Cdc42 reflects the relative amount of active Cdc42 in the lysate (24) . Injection of mRNA for wild type IQGAP1 augmented the amount of active Cdc42 in embryo lysates by 41% (p<0.05) (Fig. 4A) . By contrast, IQGAP1-∆GRD did not increase the amount of active Cdc42. This result indicates that overexpression of IQGAP1 increases the amount of active Cdc42 in the embryo, and is consistent with our earlier observation that wild type IQGAP1 downregulates the intrinsic GTPase activity of Cdc42 in vitro (13) .
We next tested the hypothesis that the effect of IQGAP1 on embryonic ectoderm is due to activation of endogenous Cdc42. This was evaluated by co-injecting dominant negative forms of Rho family proteins, namely N19Rho, N17Rac1 or N17Cdc42 (26), with wild type IQGAP1 ( To verify that the Rho family mRNAs were translated into protein, aliquots of embryo lysates were subjected to Western blotting. Probing the blots with anti-Myc antibody revealed the expression of the dominant negative Rac, Cdc42 and Rho proteins (Fig. 5B) . Inspection of the blots also verified that injected IQGAP1 protein was expressed in the embryos and that equal amounts of protein lysate were loaded on the gel (Fig. 5B , top and middle panels, respectively).
Note that IQGAP1 is not detectable in the Western blots from uninjected embryos (Fig. 4A) .
The anti-IQGAP1 antibody, which was generated using the N-terminal region (amino acids 1-863) of human IQGAP1 (13), may not recognize Xenopus IQGAP1.
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DISCUSSION
In this report, we describe the in vivo activity of IQGAP1 overexpressed in early frog embryos. Injection of wild type IQGAP1 into Xenopus early embryos induced changes at the mid-blastula stages, with more dramatic effects evident by gastrulation. Based on the morphological appearance of induced lesions in presumptive ectoderm, IQGAP1 is likely to affect the cytoskeletal architecture and cell adhesion. IQGAP1 interacts with several proteins that could modulate the cytoskeleton, including actin, E-cadherin, β-catenin, Cdc42 and Rac (10, 13, 14) . To identify the target, we created a series of mutant IQGAP1 constructs. All of the IQGAP1 regions that are known to interact with targets or contain domains likely to be involved in protein-protein interactions, e.g., the WW domain, were deleted. The known binding domains are the CHD, actin binding domain (13); IQ region, calmodulin-binding domain (13) ; GRD, necessary for Cdc42 and Rac binding (10) and the C-terminal tail, which is required for binding of E-cadherin and β-catenin (14) . Analysis of these mutant IQGAP1 proteins revealed that Cdc42 binding was necessary to produce the phenotype.
The specific region of IQGAP1 to which Cdc42 binds has not been identified. In vitro analysis with purified proteins demonstrated that the C-terminal half of IQGAP1 (amino acid residues 864-1657) bound Cdc42, but deletion of the GRD prevented Cdc42 binding (10) .
Interestingly, residues in addition to the GRD, particularly near the C-terminus, were required for binding of Cdc42 to the recombinant C-terminal half of IQGAP1 (10) . Our data with IQGAP1-∆GRD and IQGAP1-∆C extend these observations to reveal that both the GRD and C-terminal region are necessary for binding of intact IQGAP1 to endogenous Cdc42 in a normal cell milieu.
Less anticipated was the finding that IQGAP1-∆IQ was unable to bind Cdc42. Because 15 Ca 2+ /calmodulin, which binds predominantly to the IQ region of IQGAP1 (13), prevents binding of Cdc42 to IQGAP1 (9), it seems reasonable to infer that the N-terminal half of IQGAP1 imparts structural information to the intact protein. Furthermore, the conformation of IQGAP1-∆IQ is likely to resemble that of wild type IQGAP1 bound to Ca 2+ /calmodulin. Detailed structural analysis of the IQGAP1 constructs is necessary to validate this hypothesis.
Notwithstanding the documentation that IQGAP1 interacts with several proteins that regulate the cytoskeleton and cell-cell adhesion, our data identify Cdc42 as an essential component of the effect of IQGAP1 on Xenopus ectoderm. This interpretation is supported by several findings. All deletion mutants of IQGAP1 that bound Cdc42 produced the phenotype, while none of the IQGAP1 deletion mutants that failed to bind Cdc42 elicited a detectable effect.
In addition, injection of wild-type IQGAP1, but not IQGAP1-∆GRD that does not bind Cdc42, significantly increased the amount of active Cdc42 in embryo lysates. Although exhibiting substantial sequence similarity to the catalytic domain of RasGAPs (12) , in vitro analysis revealed that IQGAP1 inhibits (rather than increases, as would be anticipated for a GAP) the intrinsic GTPase activity of Cdc42 (13, Keratinocytes overexpressing CEPs (Cdc42 effector proteins) had reduced F-actin and Ecadherin at adherens junctions (34) . However, many questions remain unanswered and the specific role of Cdc42 in the regulation of cell-cell adhesion is not fully understood (35) .
Regardless of the mechanism, our data establish that IQGAP1 maintains Cdc42 in the active GTP-bound state, culminating in functional sequelae in intact cells. 
